Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti‐schistosomal Activity

The parasitic disease schistosomiasis is the cause of more than 200 000 human deaths per year. Although the disease is treatable, there is one major shortcoming: praziquantel has been the only drug used to combat these parasites since 1977. The risk of the emergence of resistant schistosomes is know...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ChemMedChem
Päätekijät: Peter Ventura, Alejandra M., Haeberlein, Simone, Lange‐Grünweller, Kerstin, Grünweller, Arnold, Hartmann, Roland K., Grevelding, Christoph G., Schlitzer, Martin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Full Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687077/
https://ncbi.nlm.nih.gov/pubmed/31454168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201900423
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia